Literature DB >> 15062487

Cholinesterase inhibitors in the treatment of Alzheimer's disease and related dementias.

Donna Masterman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15062487     DOI： 10.1016/j.cger.2003.11.002

Source DB:  PubMed          Journal:  Clin Geriatr Med        ISSN： 0749-0690            Impact factor:   3.076


× No keyword cloud information.
  3 in total

1.  The mixture of procyanidins extracted from the lotus seed pod and bilobalide ameliorates scopolamine-induced memory impairment in mice.

Authors:  Li Zhang; Ji-Qu Xu; Shuang Rong; Bi-Jun Xie; Zhi-Da Sun; Yun-Jian Zhang; Lie-Gang Liu
Journal:  Neurosci Bull       Date:  2009-08       Impact factor: 5.203

Review 2.  Trends in the molecular pathogenesis and clinical therapeutics of common neurodegenerative disorders.

Authors:  Yahya E Choonara; Viness Pillay; Lisa C Du Toit; Girish Modi; Dinesh Naidoo; Valence M K Ndesendo; Sibongile R Sibambo
Journal:  Int J Mol Sci       Date:  2009-06-03       Impact factor: 6.208

Review 3.  Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer's disease: a systematic review and meta-analysis.

Authors:  Richard A Hansen; Gerald Gartlehner; Aaron P Webb; Laura C Morgan; Charity G Moore; Daniel E Jonas
Journal:  Clin Interv Aging       Date:  2008       Impact factor: 4.458
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.